Skip to main content
bioAffinity Technologies, Inc. (BIAF)
NASDAQ: BIAF · Real-Time Price · USD
1.060
+0.020 (1.92%)
At close: Mar 9, 2026, 4:00 PM EDT
1.080
+0.020 (1.89%)
After-hours: Mar 9, 2026, 7:59 PM EDT

bioAffinity Technologies Revenue

bioAffinity Technologies had revenue of $1.45M in the quarter ending September 30, 2025, a decrease of -38.48%. This brings the company's revenue in the last twelve months to $6.78M, down -27.66% year-over-year. In the year 2024, bioAffinity Technologies had annual revenue of $9.36M with 269.68% growth.

Revenue (ttm)
$6.78M
Revenue Growth
-27.66%
P/S Ratio
0.70
Revenue / Employee
$118,890
Employees
57
Market Cap
4.76M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20249.36M6.83M269.68%
Dec 31, 20232.53M2.53M52,627.44%
Dec 31, 20224.80K--
Dec 31, 2021---
Dec 31, 2020---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Inotiv 514.03M
MDxHealth 107.88M
FONAR 106.03M
Exagen 63.60M
XWELL 29.52M
Precipio 22.80M
iSpecimen 3.35M
Mainz Biomed 659.94K
Revenue Rankings

BIAF News

More News